pillbase.ru

IDVYNSO

Active substance: DORAVIRINE, ISLATRAVIR ANHYDROUS

TABLET, FILM COATED · DORAVIRINE 100 mg/1, ISLATRAVIR ANHYDROUS .25 mg/1

United StatesActive

Marketing holder: Merck Sharp & Dohme LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing doravirine in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 4
  • Делстриго
    таблетки, покрытые пленочной оболочкой, 100 мг+300 мг+245 мг (original in Russian, GRLS)
    ЛП-№(011253)-(РГ-RU)
    ООО "МСД Фармасьютикалс"
  • Делстриго
    таблетки, покрытые пленочной оболочкой, 100 мг+300 мг+245 мг (original in Russian, GRLS)
    ЛП-005928
    ООО "МСД Фармасьютикалс"
  • Пивелтра
    таблетки, покрытые пленочной оболочкой, 100 мг (original in Russian, GRLS)
    ЛП-№(010623)-(РГ-RU)
    ООО "МСД Фармасьютикалс"
  • Пивелтра
    таблетки, покрытые пленочной оболочкой, 100 мг (original in Russian, GRLS)
    ЛП-005570
    ООО "МСД Фармасьютикалс"
EU 2
  • Delstrigo
    doravirine, lamivudine, tenofovir disoproxil fumarate
    EMEA/H/C/004746
    Merck Sharp & Dohme B.V.
  • Pifeltro
    doravirine
    EMEA/H/C/004747
    Merck Sharp & Dohme B.V.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-b71b-7dac-8426-fda67f3ba3ce,01a120c5-d1ce-7962-8495-e24f0f9eb733;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12093-8bbe-7af1-adec-048b8447890e,01a12095-9ba2-71fa-b0c4-0f76df233c69;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0006-5092
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0006-5092 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0006-5092 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0006-5092 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 0006-5092 · Verified 2026-10-09 · open in source